Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs GSK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA GSK PHARMA ALEMBIC PHARMA/
GSK PHARMA
 
P/E (TTM) x 32.2 62.2 51.8% View Chart
P/BV x 4.4 18.9 23.4% View Chart
Dividend Yield % 0.8 1.6 49.5%  

Financials

 ALEMBIC PHARMA   GSK PHARMA
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-23
GSK PHARMA
Mar-23
ALEMBIC PHARMA/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs7921,684 47.1%   
Low Rs4631,231 37.6%   
Sales per share (Unadj.) Rs287.6191.9 149.8%  
Earnings per share (Unadj.) Rs17.435.9 48.5%  
Cash flow per share (Unadj.) Rs31.439.8 79.0%  
Dividends per share (Unadj.) Rs8.0032.00 25.0%  
Avg Dividend yield %1.32.2 58.0%  
Book value per share (Unadj.) Rs222.3102.9 216.1%  
Shares outstanding (eoy) m196.56169.41 116.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.27.6 28.8%   
Avg P/E ratio x36.140.6 88.8%  
P/CF ratio (eoy) x20.036.7 54.5%  
Price / Book Value ratio x2.814.2 19.9%  
Dividend payout %46.089.2 51.5%   
Avg Mkt Cap Rs m123,402246,858 50.0%   
No. of employees `000NANA-   
Total wages/salary Rs m11,6915,950 196.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m56,52632,517 173.8%  
Other income Rs m301,007 3.0%   
Total revenues Rs m56,55733,524 168.7%   
Gross profit Rs m6,7728,033 84.3%  
Depreciation Rs m2,754658 418.8%   
Interest Rs m50218 2,768.8%   
Profit before tax Rs m3,5468,364 42.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1262,288 5.5%   
Profit after tax Rs m3,4206,076 56.3%  
Gross profit margin %12.024.7 48.5%  
Effective tax rate %3.627.4 13.0%   
Net profit margin %6.118.7 32.4%  
BALANCE SHEET DATA
Current assets Rs m29,13924,943 116.8%   
Current liabilities Rs m16,40813,264 123.7%   
Net working cap to sales %22.535.9 62.7%  
Current ratio x1.81.9 94.4%  
Inventory Days Days1097 10.0%  
Debtors Days Days7216 3.1%  
Net fixed assets Rs m31,4986,988 450.8%   
Share capital Rs m3931,694 23.2%   
"Free" reserves Rs m43,31215,735 275.2%   
Net worth Rs m43,70517,430 250.8%   
Long term debt Rs m00-   
Total assets Rs m60,63731,930 189.9%  
Interest coverage x8.1462.6 1.7%   
Debt to equity ratio x00-  
Sales to assets ratio x0.91.0 91.5%   
Return on assets %6.519.1 33.9%  
Return on equity %7.834.9 22.4%  
Return on capital %9.348.1 19.3%  
Exports to sales %46.40-   
Imports to sales %12.148.1 25.2%   
Exports (fob) Rs m26,210NA-   
Imports (cif) Rs m6,84615,630 43.8%   
Fx inflow Rs m26,2101,622 1,616.2%   
Fx outflow Rs m6,84615,630 43.8%   
Net fx Rs m19,364-14,008 -138.2%   
CASH FLOW
From Operations Rs m7,2404,842 149.5%  
From Investments Rs m-4,4768,079 -55.4%  
From Financial Activity Rs m-2,620-15,433 17.0%  
Net Cashflow Rs m144-2,512 -5.7%  

Share Holding

Indian Promoters % 69.1 0.0 -  
Foreign collaborators % 0.5 75.0 0.7%  
Indian inst/Mut Fund % 19.0 11.6 164.2%  
FIIs % 4.5 2.9 154.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 25.0 121.6%  
Shareholders   85,212 114,663 74.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   SUN PHARMA    CIPLA    DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ALEMBIC PHARMA vs GSK Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALEMBIC PHARMA vs GSK Pharma Share Price Performance

Period ALEMBIC PHARMA GSK Pharma S&P BSE HEALTHCARE
1-Day -0.15% 3.26% 1.18%
1-Month -4.30% -9.77% -0.75%
1-Year 105.43% 52.63% 61.82%
3-Year CAGR 0.89% 10.89% 18.16%
5-Year CAGR 13.56% 8.44% 19.79%

* Compound Annual Growth Rate

Here are more details on the ALEMBIC PHARMA share price and the GSK Pharma share price.

Moving on to shareholding structures...

The promoters of ALEMBIC PHARMA hold a 69.6% stake in the company. In case of GSK Pharma the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALEMBIC PHARMA and the shareholding pattern of GSK Pharma.

Finally, a word on dividends...

In the most recent financial year, ALEMBIC PHARMA paid a dividend of Rs 8.0 per share. This amounted to a Dividend Payout ratio of 46.0%.

GSK Pharma paid Rs 32.0, and its dividend payout ratio stood at 89.2%.

You may visit here to review the dividend history of ALEMBIC PHARMA, and the dividend history of GSK Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.